[Basic program of myocardial infarct after-care].
The further diagnostics and therapy is performed after classification of the patients in groups with different prognosis. The decision, whether or not an invasive diagnostics is necessary and which medicaments are prescribed is based on the results of non-invasive diagnostic measures. The beta-blockers are the most important group of medicaments. Anticoagulants and antiarrhythmic drugs are used within limited and defined indication. A broad application of thrombocyte aggregation inhibitors seems to be justified according to latest studies. The consequent elimination of coronary risk factors has ascertained prognostic effects.
Holtz
H
H
Kardiologischen Abteilung, Medizinischen Akademie Erfurt.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000359:Aftercare / Q000379:methods; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D003326:Coronary Circulation / Q000187:drug effects; D004562:Electrocardiography / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors